CMS Price Transparency: The Basics

The Centers for Medicare and Medicaid Services (CMS) released its final rule requiring hospitals to disclose payer-specific negotiated rates effective Jan. 1, 2021. Becoming familiar with the rule’s definitions will assist in making necessary changes to be compliant.
Short-Dated Products: Reducing Unsalable Returns and Supply Chain Waste

The glut of soon-to-expire products within the pharmaceutical supply chain is a costly problem impacting multiple stakeholders, but smart technology and innovative inventory management systems offer cost-saving solutions.
Complying with Rules Ensures Reimbursement for Drugs

Healthcare costs continue to rise and payment models subsequently evolve, payers nevertheless largely decide which expensive high-investment drugs will be reimbursed and under what circumstances.
CMS 2020 Proposed and Final OPPS and ASC Rules

New CMS rules focus on transparency to reduce cost in a patient-driven healthcare system.
Approaching New Payment Rules

How CMS reimbursement rules directly impact community hospitals and what payers are doing in response.
Impacts of the Opioid Crisis Response Act

The final version of the Opioid Crisis Response Act (H.R. 6) has been signed into law to address the nationwide opioid crisis by expanding and creating programs for prevention, treatment and recovery.
Proposed 2019 OPPS Rules

The proposed 2019 Outpatient Prospective Payment System rules have been published in the Federal Register and will take effect on Jan. 1, 2019.
Basic Concepts Driving Drug Payment

Medication payment rules are changing. Here’s an review of important terms and an update on proposed and enacted rule changes.
Avoiding Part B Reimbursement Pitfalls

Healthcare costs continues to rise, but practitioners can help by meeting the reimbursement requirements for Part B drugs in outpatient settings.
Revisiting Billing for Expensive Drug Waste

Billing for drug waste sounds simple, but can be confusing. These reminders can help healthcare facilities identify what is billable.